Revision de las propiedades farmacologicas del piracetam

Es interesante que haya estudios nuevos sobre el piracetam, aunque de este esté disponible sólo el abstract y parece que es una revisión de estudios anteriores.

 CNS Drug Rev. 2005 Summer;11(2):169-82.        

Piracetam: a review of pharmacological properties and clinical uses.

Winblad B.

Karolinska Institutet, Neurotec, Huddinge, University Hospital B 84, S-14186 Stockholm, Sweden.

Piracetam, a derivative of the neurotransmitter gamma-aminobutyric acid (GABA), has a variety of physiological effects that may result, at least in part, from the restoration of cell membrane fluidity. At a neuronal level, piracetam modulates neurotransmission in a range of transmitter systems (including cholinergic and glutamatergic), has neuroprotective and anticonvulsant properties, and improves neuroplasticity. At a vascular level, it appears to reduce erythrocyte adhesion to vascular endothelium, hinder vasospasm, and facilitate microcirculation. This diverse range of physiological effects is consistent with its use in a range of clinical indications. Its efficacy is documented in cognitive disorders and dementia, vertigo, cortical myoclonus, dyslexia, and sickle cell anemia. While high doses are sometimes necessary, piracetam is well tolerated.

Publication Types:
Review

PMID: 16007238 [PubMed - in process]